The clinical and Virology effects of NA inhibitor in influenza virus infections (age; over 4 years old, under 11 years old): an open-label, randomized study.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2013
At a glance
- Drugs Oseltamivir (Primary) ; Peramivir (Primary) ; Laninamivir; Zanamivir
- Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype
- Focus Therapeutic Use
- 16 Feb 2013 New trial record